adminSTERIS plc (NYSE:STE) Q1 2026 Earnings Conference Call August 7, 2025 8:30 AM ET
Company Participants
Daniel A. Carestio – President, CEO & Director
Julie Winter – Vice President of Investor Relations & Corporate Communications
Michael J. Tokich – Senior VP & CFO
Conference Call Participants
Brett Adam Fishbin – KeyBanc Capital Markets Inc., Research Division
David Howard Windley – Jefferies LLC, Research Division
Jason M. Bednar – Piper Sandler & Co., Research Division
Michael K. Polark – Wolfe Research, LLC
Michael Stephen Matson – Needham & Company, LLC, Research Division
Steven McLaurin Etoch – Stephens Inc., Research Division
Xuesong Wang – Morgan Stanley, Research Division
Operator
Good day, and welcome to the STERIS plc First Quarter 2026 Conference Call. [Operator Instructions] Please note, this event is being recorded.
I would now like to turn the conference over to Julie Winters, Investor Relations. Please go ahead.
Julie Winter
Thank you, Allen, and good morning, everyone. Speaking on today’s call will be Mike Tokich, our Senior Vice President and CFO; and Dan Carestio, our President and CEO.
And I do have a few words of caution before we open for comments from management. This webcast contains time-sensitive information that is accurate only as of today. Any redistribution, retransmission or rebroadcast of this call without the expressed written consent of STERIS is strictly prohibited.
Some of the statements made during this review are or may be considered forward-looking statements. Many important factors could cause actual results to differ materially from those in the forward-looking statements, including, without limitation, those risk factors described in STERIS’ securities filings. The company does not undertake to update or revise any forward-looking statements as a result of new information or future events or developments. STERIS’ SEC filings are available through the company and on our website.
In
Read the full article here
